• JHU-083 (SKU BA7770): Reliable Glutaminase Inhibition in Lab

  2026-06-11

  This article examines how JHU-083 (SKU BA7770), a 6-diazo-5-oxo-L-norleucine precursor from APExBIO, addresses real laboratory challenges in glutaminase pathway and neurotoxicity research. Scenario-driven Q&A blocks integrate peer-reviewed evidence and practical workflow advice, guiding biomedical scientists to reproducible, sensitive results.

• Lypressin Acetate in Translational Research: Mechanisms & St

  2026-06-10

  This thought-leadership article explores the mechanistic nuances and translational opportunities of lysine vasopressin acetate (lypressin acetate), offering actionable insights for researchers advancing antidiuretic, vasopressor, and emerging antiviral therapies. We synthesize current evidence, including mechanistic studies and real-world protocols, to provide a strategic guide for experimental design and clinical translation.

• Formononetin Shields Neurons During Oxaliplatin Chemotherapy

  2026-06-10

  This study demonstrates that formononetin, a natural isoflavone, protects sensory neurons from oxaliplatin-induced oxidative stress and apoptosis via Nrf2/HO-1 pathway activation, without reducing chemotherapy efficacy. These results highlight a promising route to address chemotherapy-induced peripheral neuropathy while preserving anticancer outcomes.

• Glioma Organoids Retaining Microenvironment for Drug Screeni

  2026-06-09

  This study introduces a glioma organoid model that faithfully preserves the tumor microenvironment, enabling more accurate drug screening and therapeutic evaluation. The model maintains genetic, epigenetic, and immune features of patient-derived gliomas, representing a significant advance for translational neuro-oncology research.

• Tp47-Induced Macrophage Senescence via PKM2 Metabolic Reprog

  2026-06-09

  This study reveals how Treponema pallidum protein Tp47 induces inflammatory senescence in macrophages through direct modulation of PKM2-mediated metabolic reprogramming, providing mechanistic insight into pathogen-driven immune evasion in syphilis. These findings advance the understanding of host-pathogen interactions and support the refinement of senescent cell detection protocols for translational research.

• BMS 309403: Applied FABP4 Inhibitor Workflows in Atheroscler

  2026-06-08

  BMS 309403 empowers lipid metabolism and inflammation researchers with precise, reproducible inhibition of FABP4, enabling advanced modeling of atherosclerosis and metabolic diseases. This guide details experimental workflows, troubleshooting, and key findings from recent studies, ensuring optimal protocol design and translational relevance.

• DNase I (RNase-free): Reliable DNA Removal for Cell Assays

  2026-06-08

  This article examines real laboratory scenarios where DNase I (RNase-free) (SKU K1088) provides robust, reproducible solutions for DNA removal in RNA extraction, RT-PCR, and chromatin workflows. Using scenario-driven Q&A, it highlights protocol optimization, assay integrity, and vendor selection strategies for researchers and technicians.

• UK-5099 (PF-1005023): Advancing Immunometabolic Assay Design

  2026-06-07

  Discover how UK-5099 (PF-1005023) empowers next-generation immunometabolic assay development. Explore its mechanistic depth, protocol parameters, and strategic insights for mitochondrial metabolism research.

• Repurposing Approved Drugs to Modulate DNA Repair in CRISPR

  2026-06-06

  This study systematically screened clinically approved drugs to identify modulators of DNA double-strand break (DSB) repair pathways during CRISPR genome editing. By uncovering compounds that shift repair outcomes or induce synthetic lethality, the work expands therapeutic opportunities in gene editing, cancer, and precision medicine.

• Protocol Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-06-05

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables high-yield synthesis of Cy3-labeled RNA probes for applications such as in situ hybridization and Northern blotting. It addresses the need for reliable, efficient fluorescent RNA probe generation in research workflows. This kit should not be used for diagnostic, therapeutic, or clinical purposes.

• Cyclic di-GMP: Applied Workflows for Biofilm and Immune Rese

  2026-06-05

  Cyclic di-GMP’s dual role as an intracellular second messenger makes it indispensable for both biofilm stability studies and cutting-edge immune modulation research. This guide translates the latest mechanistic findings into actionable protocols and troubleshooting insights, helping researchers harness APExBIO’s high-purity cyclic di-GMP for reliable, cross-domain experimentation.

• Resveratrol as a SIRT1 Activator: Mechanisms and Neuroprotec

  2026-06-04

  Explore how Resveratrol functions as a potent SIRT1 activator, modulating apoptosis and mitochondrial biogenesis for advanced neuroprotection. This article uniquely details mechanistic insights and practical assay guidance grounded in the latest molecular science.

• Okadaic acid: Technical Guide for PP1/PP2A Inhibition (A4540

  2026-06-04

  Okadaic acid is a marine-derived, nanomolar-range inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), widely used to dissect phosphorylation-dependent signaling, apoptosis, and neurochemical pathways. It is best deployed in controlled cell or biochemical assays where selective phosphatase inhibition is needed, but should not be used where broad or non-specific inhibition is desired.

• Applied Workflows for Cy3 Goat Anti-Human IgG (H+L) Antibody

  2026-06-03

  The Cy3 Goat Anti-Human IgG (H+L) Antibody streamlines human IgG detection across immunofluorescence, IHC, flow cytometry, and ELISA. Leveraging recent advances in orthopoxvirus antibody characterization, this guide delivers step-by-step workflows, cross-domain insights, and troubleshooting strategies to maximize assay sensitivity and reproducibility.

• Pharmacokinetic Variability of CSBTA in MASH: Tissue Impact

  2026-06-03

  The reference study provides the first integrated pharmacokinetic (PK) and tissue distribution analysis of Corydalis saxicola Bunting total alkaloids (CSBTA) in mouse models of metabolic dysfunction-associated steatohepatitis (MASH). By demonstrating how pathological state alters exposure, hepatic accumulation, and transporter/enzyme modulation, the findings inform rational dosing and translational drug development for MASLD/MASH interventions.

450 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page